Arovella Therapeutics Limited’s (ALA) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Arovella Therapeutics Limited is a Buy.

Arovella Therapeutics Limited’s (ALA) 20-Day exponential moving average is 0.18, while Arovella Therapeutics Limited’s (ALA) share price is AU$0.175, making it a Sell.

Arovella Therapeutics Limited’s (ALA) 50-Day exponential moving average is 0.18, while Arovella Therapeutics Limited’s (ALA) share price is AU$0.175, making it a Sell.

Arovella Therapeutics Limited (ALA) Pivot Points

Dec 22, 2024, 05:34 PM

Classic

0.15

0.16

0.17

0.18

0.19

0.20

Fibonacci

0.16

0.17

0.18

0.19

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Arovella Therapeutics Limited (ALA) Moving Averages

Dec 22, 2024, 05:34 PM

MA5

0.17Sell

MA10

0.18Sell

MA20

0.18Sell

MA50

0.18Sell

MA100

0.17Buy

0.17Sell

MA200

0.15Buy

0.16Buy

Arovella Therapeutics Limited’s (ALA) 10-Day exponential moving average is 0.18, while Arovella Therapeutics Limited’s (ALA) share price is AU$0.175, making it a Sell.

Arovella Therapeutics Limited’s (ALA) 100-Day exponential moving average is 0.17, while Arovella Therapeutics Limited’s (ALA) share price is AU$0.175, making it a Sell.

Arovella Therapeutics Limited’s (ALA) stock price is AU$0.175 and Arovella Therapeutics Limited’s (ALA) 50-day simple moving average is 0.18, creating a Sell signal.

Arovella Therapeutics Limited’s (ALA) stock price is AU$0.175 and Arovella Therapeutics Limited’s (ALA) 100-day simple moving average is 0.17, creating a Buy signal.

Arovella Therapeutics Limited’s (ALA) stock price is AU$0.175 and Arovella Therapeutics Limited’s (ALA) 200-day simple moving average is 0.15, creating a Buy signal.

Arovella Therapeutics Limited (ALA) Technical Indicators

Dec 22, 2024, 05:34 PM

RSI (14)

44.96

Neutral

STOCH (9,6)

38.10

Neutral

STOCHRSI (14)

36.90

Neutral

MACD (12,26)

>-0.01

Buy

ADX (14)

18.40

Buy

Williams %R

-71.43

Buy

CCI (14)

-116.43

Buy

ATR (14)

0.01

Ultimate Oscillator

40.04

Neutral

ROC

-5.56

Sell

Arovella Therapeutics Limited’s (ALA) Relative Strength Index (RSI) is 44.96, creating a Neutral signal.

Arovella Therapeutics Limited’s (ALA) Trend Strength Indicator (ADX) is 18.40, creating a Buy signal.

Arovella Therapeutics Limited’s (ALA) Commodity Channel Index (CCI) is -116.43, creating a Buy signal.

Arovella Therapeutics Limited’s (ALA) Price Rate of Change (ROC) is -5.56, creating a Sell signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is ALA a Buy, Hold, or Sell?

Based on ALA’s technical indicators, ALA is a Sell.

What is ALA’s RSI (14)?

ALA’s RSI (14) is 44.96, which suggests ALA is a Neutral.

What is ALA’s MACD?

ALA’s MACD is >-0.01, which suggests ALA is a Buy.

What is ALA’s 5-day moving average?

ALA’s 5-day moving average is 0.17, which suggests ALA is a Sell.

What is ALA’s 20-day moving average?

ALA 20-day moving average is 0.18, which suggests ALA is a Sell.

What is ALA’s 50-day moving average?

ALA’s 50-day moving average is 0.18, which suggests ALA is a Sell.

What is ALA’s 200-day moving average?

ALA’s 200-day moving average is 0.15, which suggests ALA is a Buy.

What is ALA’s Williams % R (14)?

ALA’s Williams % R (14) is -71.43, which suggests ALA is a Buy.

What is ALA’s CCI (14)?

ALA’s CCI (14) is -116.43, which suggests ALA is a Buy.

What is the share price of Arovella Therapeutics Limited?

Arovella Therapeutics Limited's share price is 0.17AU$.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing